VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q55189411 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000329.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q55189411‏
024 ‎‡a 0000-0002-7041-5047‏ ‎‡2 orcid‏
024 ‎‡a 7401554194‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q55189411‏
100 0 ‎‡a Thomas B. Thompson‏ ‎‡9 es‏ ‎‡9 sl‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a টমাস বি টম্পসন‏ ‎‡9 bn‏
400 0 ‎‡a Thomas B. Thompson‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Thomas B. Thompson‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state.‏
670 ‎‡a Author's Activins bind and signal via bone morphogenetic protein receptor type II‏
670 ‎‡a Author's Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.‏
670 ‎‡a Author's Alternative binding modes identified for growth and differentiation factor-associated serum protein (GASP) family antagonism of myostatin.‏
670 ‎‡a Author's Amino acid 72 of mouse and human GDF9 mature domain is responsible for altered homodimer bioactivities but has subtle effects on GDF9:BMP15 heterodimer activities‏
670 ‎‡a Author's An Evaluation of the Crystal Structure of C-terminal Truncated Apolipoprotein A-I in Solution Reveals Structural Dynamics Related to Lipid Binding.‏
670 ‎‡a Author's Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif.‏
670 ‎‡a Author's Analysis of the interaction between heparin and follistatin and heparin and follistatin-ligand complexes using surface plasmon resonance.‏
670 ‎‡a Author's Analysis of the loop-helix interaction in bundle motif protein structures.‏
670 ‎‡a Author's Beta A versus beta B: is it merely a matter of expression?‏
670 ‎‡a Author's Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation‏
670 ‎‡a Author's BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction.‏
670 ‎‡a Author's Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.‏
670 ‎‡a Author's Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.‏
670 ‎‡a Author's Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2.‏
670 ‎‡a Author's Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11‏
670 ‎‡a Author's Cytochrome b₅ reductase-cytochrome b₅ as an active P450 redox enzyme system in Phanerochaete chrysosporium: atypical properties and in vivo evidence of electron transfer capability to CYP63A2‏
670 ‎‡a Author's Development of a small-molecule screening method for inhibitors of cellular response to myostatin and activin A.‏
670 ‎‡a Author's Fibronectin-based scaffold domain proteins that bind myostatin: a patent evaluation of WO2014043344‏
670 ‎‡a Author's Functional recombinant apolipoprotein A5 that is stable at high concentrations at physiological pH‏
670 ‎‡a Author's Heparin-mediated dimerization of follistatin‏
670 ‎‡a Author's Improving the diffraction of apoA-IV crystals through extreme dehydration.‏
670 ‎‡a Author's Molecular biology of inhibin action‏
670 ‎‡a Author's MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cells‏
670 ‎‡a Author's Myostatin Attenuation In Vivo Reduces Adiposity, but Activates Adipogenesis‏
670 ‎‡a Author's Myostatin stimulates, not inihibits, C2C12 myoblast proliferation.‏
670 ‎‡a Author's Neural network prediction of the HIV-1 protease cleavage sites.‏
670 ‎‡a Author's Reply to Mottershead et al.: GDF9:BMP15 heterodimers are potent regulators of ovarian functions.‏
670 ‎‡a Author's Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function.‏
670 ‎‡a Author's Small-angle X-ray scattering of apolipoprotein A-IV reveals the importance of its termini for structural stability.‏
670 ‎‡a Author's Structural and functional analysis of tetracenomycin F2 cyclase from Streptomyces glaucescens. A type II polyketide cyclase.‏
670 ‎‡a Author's Structural basis for a functional antagonist in the transforming growth factor beta superfamily‏
670 ‎‡a Author's Structural basis for potency differences between GDF8 and GDF11.‏
670 ‎‡a Author's Structural biology: Gaining atomic level insight into the biological function of macromolecules‏
670 ‎‡a Author's Structural biology of the TGFβ family‏
670 ‎‡a Author's Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity‏
670 ‎‡a Author's Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose‏
670 ‎‡a Author's Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism‏
670 ‎‡a Author's Structure of Myostatin·Follistatin-like 3‏
670 ‎‡a Author's Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.‏
670 ‎‡a Author's Structure of the human myostatin precursor and determinants of growth factor latency.‏
670 ‎‡a Author's Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions‏
670 ‎‡a Author's The 1.5-A resolution crystal structure of bacterial luciferase in low salt conditions‏
670 ‎‡a Author's The DAN family: modulators of TGF-β signaling and beyond‏
670 ‎‡a Author's The structure of apolipoprotein A-I in high density lipoproteins.‏
670 ‎‡a Author's The structure of human apolipoprotein A-IV as revealed by stable isotope-assisted cross-linking, molecular dynamics, and small angle x-ray scattering.‏
670 ‎‡a Author's The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding‏
670 ‎‡a Author's The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding‏
670 ‎‡a Author's Three-dimensional structure of adenosylcobinamide kinase/adenosylcobinamide phosphate guanylyltransferase (CobU) complexed with GMP: evidence for a substrate-induced transferase active site‏
670 ‎‡a Author's Three-dimensional structure of adenosylcobinamide kinase/adenosylcobinamide phosphate guanylyltransferase from Salmonella typhimurium determined to 2.3 A resolution,‏
909 ‎‡a (orcid) 0000000270415047‏ ‎‡9 1‏
909 ‎‡a (scopus) 7401554194‏ ‎‡9 1‏
919 ‎‡a danfamilymodulatorsoftgfβsignalingandbeyond‏ ‎‡A The DAN family: modulators of TGF-β signaling and beyond‏ ‎‡9 1‏
919 ‎‡a consensusmodelofhumanapolipoproteina1initsmonomericandlipidfreestate‏ ‎‡A A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state.‏ ‎‡9 1‏
919 ‎‡a activinsbindandsignalviabonemorphogeneticproteinreceptortype2‏ ‎‡A Activins bind and signal via bone morphogenetic protein receptor type II‏ ‎‡9 1‏
919 ‎‡a activinsbindandsignalviabonemorphogeneticproteinreceptortype2bmpr2inimmortalizedgonadotropelikecells‏ ‎‡A Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.‏ ‎‡9 1‏
919 ‎‡a alternativebindingmodesidentifiedforgrowthanddifferentiationfactorassociatedserumproteingaspfamilyantagonismofmyostatin‏ ‎‡A Alternative binding modes identified for growth and differentiation factor-associated serum protein (GASP) family antagonism of myostatin.‏ ‎‡9 1‏
919 ‎‡a aminoacid72ofmouseandhumangdf9maturedomainisresponsibleforalteredhomodimerbioactivitiesbuthassubtleeffectsongdf9bmp15heterodimeractivities‏ ‎‡A Amino acid 72 of mouse and human GDF9 mature domain is responsible for altered homodimer bioactivities but has subtle effects on GDF9:BMP15 heterodimer activities‏ ‎‡9 1‏
919 ‎‡a evaluationofthecrystalstructureof100terminaltruncatedapolipoproteina1insolutionrevealsstructuraldynamicsrelatedtolipidbinding‏ ‎‡A An Evaluation of the Crystal Structure of C-terminal Truncated Apolipoprotein A-I in Solution Reveals Structural Dynamics Related to Lipid Binding.‏ ‎‡9 1‏
919 ‎‡a analysisandidentificationofthegrem2heparinheparansulfatebindingmotif‏ ‎‡A Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif.‏ ‎‡9 1‏
919 ‎‡a analysisoftheinteractionbetweenheparinandfollistatinandheparinandfollistatinligandcomplexesusingsurfaceplasmonresonance‏ ‎‡A Analysis of the interaction between heparin and follistatin and heparin and follistatin-ligand complexes using surface plasmon resonance.‏ ‎‡9 1‏
919 ‎‡a analysisoftheloophelixinteractioninbundlemotifproteinstructures‏ ‎‡A Analysis of the loop-helix interaction in bundle motif protein structures.‏ ‎‡9 1‏
919 ‎‡a betaaversusbetabisitmerelyamatterofexpression‏ ‎‡A Beta A versus beta B: is it merely a matter of expression?‏ ‎‡9 1‏
919 ‎‡a biochemistryandbiologyofgdf11andmyostatinsimilaritiesdifferencesandquestionsforfutureinvestigation‏ ‎‡A Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation‏ ‎‡9 1‏
919 ‎‡a bmpantagonistgremlin2limitsinflammationaftermyocardialinfarction‏ ‎‡A BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction.‏ ‎‡9 1‏
919 ‎‡a characterizationoffollistatintypedomainsandtheircontributiontomyostatinandactivinaantagonism‏ ‎‡A Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.‏ ‎‡9 1‏
919 ‎‡a circulatinggrowthdifferentiationfactor118levelsdeclinewithage‏ ‎‡A Circulating Growth Differentiation Factor 11/8 Levels Decline With Age.‏ ‎‡9 1‏
919 ‎‡a coordinatedproliferationanddifferentiationofhumaninducedpluripotentstemcellderivedcardiacprogenitorcellsdependonbonemorphogeneticproteinsignalingregulationbygremlin2‏ ‎‡A Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2.‏ ‎‡9 1‏
919 ‎‡a crystalstructureofthewfikkn2follistatindomainrevealsinsightintohowitinhibitsgrowthdifferentiationfactor8gdf8andgdf11‏ ‎‡A Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11‏ ‎‡9 1‏
919 ‎‡a cytochromeb5reductasecytochromeb5asanactivep450redoxenzymesysteminphanerochaetechrysosporiumatypicalpropertiesandinvivoevidenceofelectrontransfercapabilitytocyp63a2‏ ‎‡A Cytochrome b₅ reductase-cytochrome b₅ as an active P450 redox enzyme system in Phanerochaete chrysosporium: atypical properties and in vivo evidence of electron transfer capability to CYP63A2‏ ‎‡9 1‏
919 ‎‡a developmentofasmallmoleculescreeningmethodforinhibitorsofcellularresponsetomyostatinandactivina‏ ‎‡A Development of a small-molecule screening method for inhibitors of cellular response to myostatin and activin A.‏ ‎‡9 1‏
919 ‎‡a fibronectinbasedscaffolddomainproteinsthatbindmyostatinapatentevaluationofwo2014043344‏ ‎‡A Fibronectin-based scaffold domain proteins that bind myostatin: a patent evaluation of WO2014043344‏ ‎‡9 1‏
919 ‎‡a functionalrecombinantapolipoproteina5thatisstableathighconcentrationsatphysiologicalph‏ ‎‡A Functional recombinant apolipoprotein A5 that is stable at high concentrations at physiological pH‏ ‎‡9 1‏
919 ‎‡a heparinmediateddimerizationoffollistatin‏ ‎‡A Heparin-mediated dimerization of follistatin‏ ‎‡9 1‏
919 ‎‡a improvingthediffractionofapoa4crystalsthroughextremedehydration‏ ‎‡A Improving the diffraction of apoA-IV crystals through extreme dehydration.‏ ‎‡9 1‏
919 ‎‡a molecularbiologyofinhibinaction‏ ‎‡A Molecular biology of inhibin action‏ ‎‡9 1‏
919 ‎‡a muskisabmpcoreceptorthatshapesbmpresponsesandcalciumsignalinginmusclecells‏ ‎‡A MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cells‏ ‎‡9 1‏
919 ‎‡a myostatinstimulatesnotinihibitsc2c12myoblastproliferation‏ ‎‡A Myostatin stimulates, not inihibits, C2C12 myoblast proliferation.‏ ‎‡9 1‏
919 ‎‡a neuralnetworkpredictionofthehiv1proteasecleavagesites‏ ‎‡A Neural network prediction of the HIV-1 protease cleavage sites.‏ ‎‡9 1‏
919 ‎‡a replytomottersheadetalgdf9bmp15heterodimersarepotentregulatorsofovarianfunctions‏ ‎‡A Reply to Mottershead et al.: GDF9:BMP15 heterodimers are potent regulators of ovarian functions.‏ ‎‡9 1‏
919 ‎‡a roleofconservedprolineresiduesinhumanapolipoproteina4structureandfunction‏ ‎‡A Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function.‏ ‎‡9 1‏
919 ‎‡a smallangle10rayscatteringofapolipoproteina4revealstheimportanceofitsterminiforstructuralstability‏ ‎‡A Small-angle X-ray scattering of apolipoprotein A-IV reveals the importance of its termini for structural stability.‏ ‎‡9 1‏
919 ‎‡a structuralandfunctionalanalysisoftetracenomycinf2cyclasefromstreptomycesglaucescensatype2polyketidecyclase‏ ‎‡A Structural and functional analysis of tetracenomycin F2 cyclase from Streptomyces glaucescens. A type II polyketide cyclase.‏ ‎‡9 1‏
919 ‎‡a structuralbasisforafunctionalantagonistinthetransforminggrowthfactorbetasuperfamily‏ ‎‡A Structural basis for a functional antagonist in the transforming growth factor beta superfamily‏ ‎‡9 1‏
919 ‎‡a structuralbasisforpotencydifferencesbetweengdf8andgdf11‏ ‎‡A Structural basis for potency differences between GDF8 and GDF11.‏ ‎‡9 1‏
919 ‎‡a structuralbiologygainingatomiclevelinsightintothebiologicalfunctionofmacromolecules‏ ‎‡A Structural biology: Gaining atomic level insight into the biological function of macromolecules‏ ‎‡9 1‏
919 ‎‡a structuralbiologyofthetgfβfamily‏ ‎‡A Structural biology of the TGFβ family‏ ‎‡9 1‏
919 ‎‡a structuralcharacterizationofanactivinclassternaryreceptorcomplexrevealsa3paradigmforreceptorspecificity‏ ‎‡A Structural characterization of an activin class ternary receptor complex reveals a third paradigm for receptor specificity‏ ‎‡9 1‏
919 ‎‡a structuralstudiesoftheparainfluenzavirus5hemagglutininneuraminidasetetramerincomplexwithitsreceptorsialyllactose‏ ‎‡A Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose‏ ‎‡9 1‏
919 ‎‡a structureofgremlin2incomplexwithgdf5givesinsightintodanfamilymediatedbmpantagonism‏ ‎‡A Structure of Gremlin-2 in Complex with GDF5 Gives Insight into DAN-Family-Mediated BMP Antagonism‏ ‎‡9 1‏
919 ‎‡a structureofmyostatinfollistatinlike3‏ ‎‡A Structure of Myostatin·Follistatin-like 3‏ ‎‡9 1‏
919 ‎‡a structureofneuroblastomasuppressoroftumorigenicity1nbl1insightsforthefunctionalvariabilityacrossbonemorphogeneticproteinbmpantagonists‏ ‎‡A Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.‏ ‎‡9 1‏
919 ‎‡a structureofthehumanmyostatinprecursoranddeterminantsofgrowthfactorlatency‏ ‎‡A Structure of the human myostatin precursor and determinants of growth factor latency.‏ ‎‡9 1‏
919 ‎‡a structuresofanactriibactivinacomplexrevealanovelbindingmodefortgfbetaligandreceptorinteractions‏ ‎‡A Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions‏ ‎‡9 1‏
919 ‎‡a 15aresolutioncrystalstructureofbacterialluciferaseinlowsaltconditions‏ ‎‡A The 1.5-A resolution crystal structure of bacterial luciferase in low salt conditions‏ ‎‡9 1‏
919 ‎‡a structureofapolipoproteina1inhighdensitylipoproteins‏ ‎‡A The structure of apolipoprotein A-I in high density lipoproteins.‏ ‎‡9 1‏
919 ‎‡a structureofhumanapolipoproteina4asrevealedbystableisotopeassistedcrosslinkingmoleculardynamicsandsmallangle10rayscattering‏ ‎‡A The structure of human apolipoprotein A-IV as revealed by stable isotope-assisted cross-linking, molecular dynamics, and small angle x-ray scattering.‏ ‎‡9 1‏
919 ‎‡a structureofmyostatinfollistatin288insightsintoreceptorutilizationandheparinbinding‏ ‎‡A The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding‏ ‎‡9 1‏
919 ‎‡a structureofthefollistatinactivincomplexrevealsantagonismofbothtype1andtype2receptorbinding‏ ‎‡A The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding‏ ‎‡9 1‏
919 ‎‡a 3dimensionalstructureofadenosylcobinamidekinaseadenosylcobinamidephosphateguanylyltransferasecobucomplexedwithgmpevidenceforasubstrateinducedtransferaseactivesite‏ ‎‡A Three-dimensional structure of adenosylcobinamide kinase/adenosylcobinamide phosphate guanylyltransferase (CobU) complexed with GMP: evidence for a substrate-induced transferase active site‏ ‎‡9 1‏
919 ‎‡a 3dimensionalstructureofadenosylcobinamidekinaseadenosylcobinamidephosphateguanylyltransferasefromsalmonellatyphimuriumdeterminedto23aresolution‏ ‎‡A Three-dimensional structure of adenosylcobinamide kinase/adenosylcobinamide phosphate guanylyltransferase from Salmonella typhimurium determined to 2.3 A resolution,‏ ‎‡9 1‏
919 ‎‡a myostatinattenuationinvivoreducesadipositybutactivatesadipogenesis‏ ‎‡A Myostatin Attenuation In Vivo Reduces Adiposity, but Activates Adipogenesis‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 CAOONL|ncf11043043‏
996 ‎‡2 ISNI|000000005140038X‏
996 ‎‡2 ISNI|0000000045952575‏
996 ‎‡2 LC|no2003049901‏
996 ‎‡2 ISNI|0000000043449327‏
996 ‎‡2 ISNI|0000000063586601‏
996 ‎‡2 SUDOC|034312498‏
996 ‎‡2 LC|nb2014006175‏
996 ‎‡2 NLA|000035979691‏
996 ‎‡2 ISNI|0000000108629768‏
996 ‎‡2 NTA|19167088X‏
996 ‎‡2 DNB|1025271963‏
996 ‎‡2 ISNI|0000000496804387‏
996 ‎‡2 SUDOC|077078144‏
996 ‎‡2 LC|n 78012799‏
996 ‎‡2 ISNI|0000000085984977‏
996 ‎‡2 LC|n 2002054945‏
996 ‎‡2 LC|no2008071332‏
996 ‎‡2 N6I|vtls000013463‏
996 ‎‡2 ISNI|0000000078906786‏
996 ‎‡2 DNB|1177157608‏
996 ‎‡2 N6I|vtls001409549‏
996 ‎‡2 J9U|987007274595905171‏
996 ‎‡2 PLWABN|9811341957405606‏
996 ‎‡2 ISNI|0000000107131837‏
996 ‎‡2 CAOONL|ncf10102126‏
996 ‎‡2 N6I|vtls000280124‏
996 ‎‡2 LC|no2010016269‏
996 ‎‡2 ISNI|0000000038891321‏
996 ‎‡2 ISNI|0000000030951932‏
996 ‎‡2 ISNI|0000000032140527‏
996 ‎‡2 DNB|17299795X‏
996 ‎‡2 NII|DA04065879‏
996 ‎‡2 CAOONL|ncf11331117‏
996 ‎‡2 BNF|14141101‏
996 ‎‡2 LC|no2024098940‏
996 ‎‡2 NTA|339704543‏
996 ‎‡2 NTA|398740437‏
996 ‎‡2 BIBSYS|5012625‏
996 ‎‡2 NSK|000187404‏
996 ‎‡2 LC|no2020022243‏
996 ‎‡2 J9U|987007446956805171‏
996 ‎‡2 CAOONL|ncf10004629‏
996 ‎‡2 ISNI|0000000067547474‏
996 ‎‡2 SUDOC|189374217‏
996 ‎‡2 NII|DA06963922‏
996 ‎‡2 NUKAT|n 2010119729‏
996 ‎‡2 ISNI|0000000074082978‏
996 ‎‡2 NTA|071355820‏
996 ‎‡2 LC|n 2011046606‏
996 ‎‡2 LC|no 00061621‏
996 ‎‡2 DBC|87097969015468‏
996 ‎‡2 ISNI|0000000028864821‏
996 ‎‡2 SUDOC|245080031‏
996 ‎‡2 N6I|vtls000374397‏
996 ‎‡2 NTA|338448519‏
996 ‎‡2 ISNI|0000000038612257‏
996 ‎‡2 LC|no 90016493‏
996 ‎‡2 B2Q|0000004162‏
996 ‎‡2 DNB|1187357758‏
996 ‎‡2 ISNI|0000000067638392‏
996 ‎‡2 LC|n 98007914‏
996 ‎‡2 ISNI|0000000041931304‏
996 ‎‡2 LC|n 79108650‏
996 ‎‡2 BNF|12091386‏
996 ‎‡2 LC|n 82226153‏
996 ‎‡2 BNF|12368482‏
996 ‎‡2 LC|nr2001013453‏
996 ‎‡2 ISNI|0000000034479962‏
996 ‎‡2 ISNI|0000000063060386‏
996 ‎‡2 ISNI|0000000051278855‏
996 ‎‡2 ISNI|0000000499161743‏
996 ‎‡2 ISNI|000000002126134X‏
996 ‎‡2 ISNI|0000000021509130‏
996 ‎‡2 LC|n 2022068990‏
996 ‎‡2 DNB|1139735284‏
996 ‎‡2 ISNI|0000000081452500‏
996 ‎‡2 LC|nr 91025801‏
996 ‎‡2 ISNI|0000000023274320‏
996 ‎‡2 LC|nr 91025807‏
996 ‎‡2 LC|nr 91025806‏
996 ‎‡2 LC|nr 91025809‏
996 ‎‡2 N6I|vtls000037857‏
996 ‎‡2 JPG|500073106‏
996 ‎‡2 NTA|071358412‏
996 ‎‡2 ISNI|0000000046650093‏
996 ‎‡2 BIBSYS|90766674‏
996 ‎‡2 LC|no2018032295‏
996 ‎‡2 SUDOC|070954143‏
996 ‎‡2 RERO|A025000990‏
996 ‎‡2 NLA|000035613990‏
996 ‎‡2 NLA|000035812671‏
996 ‎‡2 LC|no 89016145‏
996 ‎‡2 LC|no2002005419‏
996 ‎‡2 SUDOC|149117671‏
996 ‎‡2 BNC|981058516527206706‏
996 ‎‡2 ISNI|0000000020009265‏
996 ‎‡2 LC|n 91044512‏
996 ‎‡2 RERO|A003898523‏
996 ‎‡2 RERO|A003898520‏
996 ‎‡2 RERO|A003898521‏
996 ‎‡2 RERO|A003898524‏
996 ‎‡2 LC|n 88072733‏
996 ‎‡2 DNB|1212668707‏
996 ‎‡2 N6I|vtls000250784‏
996 ‎‡2 NSK|000062195‏
996 ‎‡2 NII|DA04376904‏
996 ‎‡2 LC|no2011081405‏
996 ‎‡2 J9U|987007365267505171‏
996 ‎‡2 DNB|134539443‏
996 ‎‡2 LC|n 2009017795‏
996 ‎‡2 LC|n 93080290‏
996 ‎‡2 RERO|A003898519‏
996 ‎‡2 CAOONL|ncf11936888‏
996 ‎‡2 LC|no2007129448‏
996 ‎‡2 LC|nr2005021907‏
996 ‎‡2 LC|n 87938924‏
996 ‎‡2 ISNI|0000000075724784‏
996 ‎‡2 ISNI|0000000026747568‏
996 ‎‡2 ISNI|0000000389833801‏
996 ‎‡2 ISNI|0000000044498796‏
996 ‎‡2 CAOONL|ncf11198375‏
996 ‎‡2 ISNI|0000000058693381‏
996 ‎‡2 NTA|070533105‏
996 ‎‡2 NTA|071568212‏
996 ‎‡2 BNE|XX4580329‏
996 ‎‡2 BNF|12642147‏
996 ‎‡2 N6I|vtls001098484‏
996 ‎‡2 LC|no2013140721‏
996 ‎‡2 NTA|073239518‏
996 ‎‡2 LC|n 85347771‏
996 ‎‡2 LC|nr 95046297‏
996 ‎‡2 J9U|987007330295405171‏
996 ‎‡2 NUKAT|n 2014097893‏
996 ‎‡2 LC|n 84184309‏
996 ‎‡2 ISNI|0000000021276103‏
996 ‎‡2 RERO|A022825184‏
996 ‎‡2 LC|n 83163932‏
996 ‎‡2 ISNI|0000000109711077‏
996 ‎‡2 RERO|A011743802‏
996 ‎‡2 DNB|1260697517‏
996 ‎‡2 BIBSYS|90767407‏
996 ‎‡2 LC|n 81120329‏
996 ‎‡2 LC|nb2019012063‏
996 ‎‡2 PLWABN|9814016035805606‏
996 ‎‡2 LC|no 00092376‏
996 ‎‡2 CAOONL|ncf10173780‏
996 ‎‡2 LC|no2020114420‏
996 ‎‡2 LC|no2001015223‏
996 ‎‡2 ISNI|0000000042849310‏
996 ‎‡2 LC|no2020021807‏
996 ‎‡2 N6I|vtls000005073‏
996 ‎‡2 NUKAT|n 00053362‏
996 ‎‡2 BIBSYS|90196610‏
996 ‎‡2 BAV|495_263333‏
996 ‎‡2 LC|n 2016019135‏
996 ‎‡2 DNB|1194315062‏
996 ‎‡2 DNB|1051901219‏
996 ‎‡2 ISNI|0000000052260366‏
996 ‎‡2 RERO|A024418070‏
996 ‎‡2 LC|n 80072234‏
996 ‎‡2 LC|no2022099247‏
996 ‎‡2 LC|no2022030518‏
996 ‎‡2 ISNI|0000000123680481‏
996 ‎‡2 SIMACOB|91379043‏
996 ‎‡2 ISNI|0000000077186668‏
996 ‎‡2 SUDOC|077250923‏
996 ‎‡2 NDL|00458679‏
996 ‎‡2 RERO|A003898518‏
996 ‎‡2 ISNI|000000039930900X‏
996 ‎‡2 LC|no 93021869‏
996 ‎‡2 DNB|1148293795‏
996 ‎‡2 RERO|A003898517‏
996 ‎‡2 LC|nr 00023974‏
996 ‎‡2 RERO|A003898514‏
996 ‎‡2 LC|n 86832495‏
996 ‎‡2 BIBSYS|90316277‏
996 ‎‡2 LC|n 82256243‏
996 ‎‡2 NII|DA03048819‏
996 ‎‡2 ISNI|0000000084461963‏
996 ‎‡2 CAOONL|ncf11169759‏
996 ‎‡2 ISNI|0000000501188049‏
996 ‎‡2 RERO|A022887893‏
996 ‎‡2 RERO|A022955481‏
996 ‎‡2 NLA|000035656120‏
996 ‎‡2 LC|nb2007014583‏
996 ‎‡2 LC|n 88246590‏
996 ‎‡2 ISNI|0000000067902106‏
996 ‎‡2 ISNI|0000000425072174‏
996 ‎‡2 NII|DA08815675‏
996 ‎‡2 BLBNB|000368970‏
996 ‎‡2 LC|no2011135327‏
996 ‎‡2 ISNI|0000000382334890‏
996 ‎‡2 ISNI|0000000053880022‏
996 ‎‡2 ISNI|0000000384390909‏
996 ‎‡2 LC|n 82023327‏
996 ‎‡2 LC|no2010186473‏
996 ‎‡2 CAOONL|ncf11281752‏
996 ‎‡2 J9U|987007268974905171‏
996 ‎‡2 NLA|000035813448‏
996 ‎‡2 NTA|129562009‏
996 ‎‡2 DBC|87097992323064‏
996 ‎‡2 NII|DA06779592‏
996 ‎‡2 LC|no 99053590‏
996 ‎‡2 ISNI|0000000031649225‏
996 ‎‡2 PLWABN|9814026474705606‏
996 ‎‡2 CAOONL|ncf11653463‏
996 ‎‡2 ISNI|0000000084357402‏
996 ‎‡2 LC|no2002065016‏
996 ‎‡2 ISNI|0000000448864158‏
996 ‎‡2 ISNI|0000000117766852‏
996 ‎‡2 LC|no2006016699‏
996 ‎‡2 SUDOC|157718778‏
996 ‎‡2 DNB|141244097‏
996 ‎‡2 ISNI|0000000082335357‏
996 ‎‡2 LC|nr 90024945‏
996 ‎‡2 ISNI|0000000028876646‏
996 ‎‡2 LC|n 88130752‏
996 ‎‡2 LC|n 88158963‏
996 ‎‡2 LC|n 88058096‏
996 ‎‡2 ISNI|0000000046555715‏
996 ‎‡2 ISNI|0000000048957275‏
996 ‎‡2 BNF|12322570‏
996 ‎‡2 ISNI|0000000086031983‏
996 ‎‡2 NTA|071686096‏
996 ‎‡2 LC|nb2023003823‏
996 ‎‡2 ISNI|0000000052582875‏
996 ‎‡2 ISNI|000000002860240X‏
996 ‎‡2 ISNI|0000000499118489‏
996 ‎‡2 DNB|137118201‏
996 ‎‡2 NTA|079916260‏
996 ‎‡2 LC|n 95032887‏
996 ‎‡2 LC|n 87860878‏
996 ‎‡2 BIBSYS|1012857‏
996 ‎‡2 NDL|00458680‏
996 ‎‡2 ISNI|0000000039407407‏
996 ‎‡2 LC|no2009180151‏
996 ‎‡2 LC|n 2001028977‏
996 ‎‡2 LC|n 87810243‏
996 ‎‡2 BNE|XX1724206‏
996 ‎‡2 DE633|pe30014506‏
996 ‎‡2 ISNI|0000000430389598‏
996 ‎‡2 ISNI|0000000082721063‏
996 ‎‡2 NLA|000035875421‏
996 ‎‡2 LC|n 89625935‏
996 ‎‡2 NII|DA10048488‏
996 ‎‡2 ISNI|0000000037577226‏
996 ‎‡2 LC|n 95006706‏
996 ‎‡2 CAOONL|ncf10056775‏
996 ‎‡2 ISNI|0000000103171997‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏